New Pathways and Therapeutic Targets in Autoimmune Myasthenia Gravis

Journal of Neuromuscular Diseases - Netherlands
doi 10.3233/jnd-170294
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

IOS Press

Related search

Refractory Myasthenia Gravis – Patient Burden and the Need for New Therapeutic Targets

European Neurological Review
Neurology
2018English

Ephedrine Treatment for Autoimmune Myasthenia Gravis

Neuromuscular Disorders
Child HealthNeurologyPediatricsPerinatologyGenetics
2017English

Complicating Autoimmune Diseases in Myasthenia Gravis: A Review

Autoimmunity
AllergyImmunology
2015English

Autoimmune Myasthenia Gravis: Emerging Clinical and Biological Heterogeneity

The Lancet Neurology
Neurology
2009English

Immunosuppression of Experimental Autoimmune Myasthenia Gravis by Mycophenolate Mofetil

Journal of Neuroimmunology
AllergyImmunologyNeurology
2008English

Myasthenia Gravis

CMAJ
Medicine
2018English

Myasthenia Gravis

Postgraduate Medical Journal
Medicine
1965English

Effect of Therapeutic Plasma Exchange on Immunoglobulins in Myasthenia Gravis

Autoimmunity
AllergyImmunology
2016English

Myasthenia Gravis

Seminars in Neurology
Neurology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy